The Alzheimer’s Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer’s-Focused Studies

[1] Wimo A(2017)The worldwide costs of dementia 2015 and comparisons with 2010 Alzheimers Dement. 13 1-7

[2] Guerchet M(2018)2018 Alzheimer’s Disease Facts and Figures Alzheimers Dement 14 367-429

[3] Ali GC(1998)Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset Am.J.Public Health 88 1337-42

[4] Brookmeyer R(2017)Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer’s Disease Prevention J Prev Alzheimers Dis 44 213-4

[5] Gray S(2019)Alzheimer’s disease drug development pipeline: 2019 Alzheimers Dement (N.Y.) 5 272-93

[6] Kawas C(2012)A model for the design and implementation of a participant recruitment registry for clinical studies of older adults Clin.Trials 9 204-14

[7] Alber J(2013)Evaluating various areas of process improvement in an effort to improve clinical research: discussions from the 2012 Clinical Translational Science Award (CTSA) Clinical Research Management workshop Clin.Transl.Sci. 6 317-20

[8] Lee AKW(2014)Facilitating Alzheimer disease research recruitment Alzheimer Dis.Assoc.Disord. 281 1-8

[9] Menard W(2012)Recruitment methods for United States Alzheimer disease prevention trials J Nutr.Health Aging 16 331-5

[10] Monast D(2010)Addressing the challenges to successful recruitment and retention in Alzheimer’s disease clinical trials Alzheimers.Res.Ther. 2 34-45

[1] Wimo A(2017)The worldwide costs of dementia 2015 and comparisons with 2010 Alzheimers Dement. 13 1-7

[2] Guerchet M(2018)2018 Alzheimer’s Disease Facts and Figures Alzheimers Dement 14 367-429

[3] Ali GC(1998)Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset Am.J.Public Health 88 1337-42

[4] Brookmeyer R(2017)Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer’s Disease Prevention J Prev Alzheimers Dis 44 213-4

[5] Gray S(2019)Alzheimer’s disease drug development pipeline: 2019 Alzheimers Dement (N.Y.) 5 272-93

[6] Kawas C(2012)A model for the design and implementation of a participant recruitment registry for clinical studies of older adults Clin.Trials 9 204-14

[7] Alber J(2013)Evaluating various areas of process improvement in an effort to improve clinical research: discussions from the 2012 Clinical Translational Science Award (CTSA) Clinical Research Management workshop Clin.Transl.Sci. 6 317-20

[8] Lee AKW(2014)Facilitating Alzheimer disease research recruitment Alzheimer Dis.Assoc.Disord. 281 1-8

[9] Menard W(2012)Recruitment methods for United States Alzheimer disease prevention trials J Nutr.Health Aging 16 331-5

[10] Monast D(2010)Addressing the challenges to successful recruitment and retention in Alzheimer’s disease clinical trials Alzheimers.Res.Ther. 2 34-45